A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray-Reference-Cited by-同舟云学术

A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray

Published:2012-11-22 Issue:5 Volume:69 Page:1135-1147
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Stott C. G.,White L.,Wright S.,Wilbraham D.,Guy G. W.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-012-1441-0.pdf

Reference23 articles.

1. Richards RG, Sampson FC, Beard SM, Tappenden P (2002) A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models. Health Tech Assess 6(10):1–73

2. Fox A, Bevans S (2005) Therapeutic potential of cannabinoid system and its mechanisms in pain control. Expert Opin Investig Drugs 14(6):695–703

3. Rog DJ, Nurmikko TJ, Friede T, Young CA (2005) Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 8:283–291

4. Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT et al (2010) Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage 39(2):167–179

5. Rog DJ, Nurmikko TJ, Young CA (2007) Oromucosal delta-9- tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial. Clin Ther 29(9):2068–2079

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety Assessment on Isolated Cannabidiol (CBD) as a Novel Food for Use in Food Supplements (RP427);FSA Research and Evidence;2024-08-15

2. Potential analgesic effect of a novel cannabidiol nanocrystals powder for the treatment of neuropathic pain;European Journal of Pain;2024-07-09

3. Quantitative summary on the human pharmacokinetic properties of cannabidiol to accelerate scientific clinical application of cannabis;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-08

4. Cannabidiol for Treatment of Child and Adolescent Psychiatric Disorders;Psychiatric Annals;2024-06

5. Solubility Enhancement and Antioxidation Maintenance of CBD Encapsulated in the P407-RUB Nano-micelle System;Current Drug Delivery;2024-02